PFBT
ADMA icon

Parkside Financial Bank & Trust’s ADMA Biologics ADMA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-529
Closed -$4.77K – 2704
2026
Q1 		$4.77K Buy
529
+242
+84% +$3.82K ﹤0.01% 1840
2025
Q4 		$5.24K Buy
287
+165
+135% +$2.78K ﹤0.01% 1786
2025
Q3 		$1.79K Sell
122
-23
-16% -$394 ﹤0.01% 2066
2025
Q2 		$2.64K Buy
145
+20
+16% +$408 ﹤0.01% 1902
2025
Q1 		$2.48K Buy
125
+86
+221% +$1.49K ﹤0.01% 1824
2024
Q4 		$669 Buy
39
+9
+30% +$169 ﹤0.01% 1807
2024
Q3 		$600 Buy
+30
New +$467 ﹤0.01% 1798

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Parkside Financial Bank & Trust's ADMA Position: Q2 2026 in Review

Parkside Financial Bank & Trust sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 529 shares — an estimated $4.77K sold.

Parkside Financial Bank & Trust first reported a position in ADMA in Q3 2024 and held it in 7 quarters. The position peaked at $5.24K in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Parkside Financial Bank & Trust reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 529 ADMA Biologics shares in Q2 2026, an estimated $4.77K.
  • Parkside Financial Bank & Trust first reported a position in ADMA Biologics in Q3 2024 and held it in 7 quarters.
  • Parkside Financial Bank & Trust's ADMA Biologics position peaked at $5.24K in Q4 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.